Journal: Cytogenetic and Genome Research
Submission Deadline: August 31, 2025
Cytogenetic and Genome Research is pleased to announce this call for papers for submissions from cancer biology and molecular genetics researchers. This collection will explore the genetic and molecular mechanisms that influence cancer therapy and resistance.
We welcome submissions that present substantial experimental work, and that advance our understanding of the role of molecular factors in cancer biology and therapy.
Bioinformatics analyses will only be considered if complemented by experimental validation. Therefore, submissions must present original experimental findings and meaningful insights into cancer biology and therapy.
Topics of interest include, but are not limited to:
- Specific genetic mutations and alterations driving therapy outcomes
- Mechanisms by which genetic elements (e.g., lncRNAs, microRNAs, or other noncoding RNAs) modulate cancer cell response to therapy
- Approaches to overcome resistance to chemotherapy or radiation therapy
Please select the option “Call for Papers: Cancer Biology and Therapy” when submitting your manuscript and mention this Call for Papers in your cover letter.
Cytogenetic and Genome Research supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.
Check out the Author Guidelines.